Explore
Validate
LearnAHC0132
antibody from Invitrogen Antibodies
Targeting: IL13
ALRH, BHR1, IL-13, MGC116786, MGC116788, MGC116789, P600
Western blot
Flow cytometryAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Flow cytometry [1]
- Other assay [3]
Submit
Validation data
Reference
Comment
Report error
- Product number
- AHC0132 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- IL-13 Monoclonal Antibody (JES10-5A2)
- Antibody type
- Monoclonal
- Antigen
- Purifed from natural sources
- Reactivity
- Human
- Host
- Rat
- Isotype
- IgG
- Antibody clone number
- JES10-5A2
- Vial size
- 500 µg
- Concentration
- 1 mg/mL
- Storage
- -20°C
Submitted references Cross-talk between Colon Cells and Macrophages Increases ST6GALNAC1 and MUC1-sTn Expression in Ulcerative Colitis and Colitis-Associated Colon Cancer.
Interleukin (IL)-13 and IL-17A contribute to neo-osteogenesis in chronic rhinosinusitis by inducing RUNX2.
Variation of T-cell activation in allergic subjects during natural pollen exposure.
Assessment of T lymphocyte cytokine production in induced sputum from asthmatics: a flow cytometry study.
Kvorjak M, Ahmed Y, Miller ML, Sriram R, Coronnello C, Hashash JG, Hartman DJ, Telmer CA, Miskov-Zivanov N, Finn OJ, Cascio S
Cancer immunology research 2020 Feb;8(2):167-178
Cancer immunology research 2020 Feb;8(2):167-178
Interleukin (IL)-13 and IL-17A contribute to neo-osteogenesis in chronic rhinosinusitis by inducing RUNX2.
Khalmuratova R, Shin HW, Kim DW, Park JW
EBioMedicine 2019 Aug;46:330-341
EBioMedicine 2019 Aug;46:330-341
Variation of T-cell activation in allergic subjects during natural pollen exposure.
Koscher V, Milhe F, El Biaze M, Vervloet D, Magnan A
Allergy 2006 Jan;61(1):35-42
Allergy 2006 Jan;61(1):35-42
Assessment of T lymphocyte cytokine production in induced sputum from asthmatics: a flow cytometry study.
Boniface S, Koscher V, Mamessier E, El Biaze M, Dupuy P, Lorec AM, Guillot C, Badier M, Bongrand P, Vervloet D, Magnan A
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2003 Sep;33(9):1238-43
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2003 Sep;33(9):1238-43
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Human IL-13 Antibody. Isolated human PBMCs were stimulated and stained with the rat anti-human IL-13 R-PE. Data obtained represent the gated lymphocyte population. The diagram shows stimulated lymphocytes stained with rat anti-human IL-13 R-PE.
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- NULL
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- NULL
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Fig. 4 The effect of IL-13 neutralization on RUNX2 expression in C2C12 cells. (a-c) Blocking IL - 13 activity with a neutralizing antibody (0.5 mug/ml) reduced RUNX2 protein level in C2C12 cells treated with tissue extracts from eosinophilic CRSwNP. Whole cell extracts were immunoblotted with the indicated antibodies. (d) Osteoblast differentiation was monitored by staining ALP and by measuring its activity at day 7. Calcium deposition was assessed by staining with alizarin red S at day 21. Data are expressed as mean +- SD. * P < .05, ** P < .01. Scale bar = 200 mum. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) Fig. 4
